The European Union has taken advantage of the goodwill and generosity of the United States, and American Taxpayers, since its inception.
Despite President Trump's historically unprecedented victory by signing a landmark trade deal in July of this year, the European Union continues to take advantage of the United States, primarily regarding pharmaceutical patents and intellectual property rights.
Europe's Regulatory Data Protection (RDP) cuts will have a devastating effect on innovation, and American taxpayers will get stuck footing the bill for almost all future pharmaceutical innovations.
If

Heads up before the FOMC meeting decision tomorrow

BREAKING: Bitcoin shorts

This is not Gold, Bitcoin or even a shitcoin. It’s Ethereum

In one word, what will Jerome Powell say tomorrow?

This is not Bitcoin, Ethereum or even a shitcoin. It’s Nvidia

Smashing capitalism with a $12 Starbucks, $200 Ray-Bans and $2,000 MacBook